The landscape of obesity treatment is changing rapidly. With more FDA-approved GLP-1 medications becoming available, people affected by obesity now have treatment options that were not accessible in the past. As costs decline and insurance coverage slowly expands, now is an important time to review your options and understand potential benefits. The Obesity Action Coalition (OAC) supports increased access to science-based treatments, which can improve health outcomes when used under the guidance of a healthcare provider. However, access to these treatments is still not guaranteed for everyone. Coverage often varies by health plan, employer or state, leaving many with high out-of-pocket costs or uncertainty. In this evolving healthcare and media landscape, reviewing your insurance coverage is more important than ever.

At the same time, cultural conversations about obesity are becoming more visible. High-profile moments, such as the 2026 Super Bowl, reflected a noticeable shift in how bodies, health and treatment are portrayed. While increased visibility can help move obesity out of the shadows, some messaging continues to rely on weight stigma and blame. Weight stigma is not a motivator, it is a barrier. Decades of research show that stigmatizing language and portrayals worsen health outcomes, increase stress and discourage people from seeking medical care. Accurate, respectful and person-first messaging is essential to support health, dignity and access to science-based treatment.

As awareness of obesity and its treatments grows, access and safety remain critical. Unfortunately, not all programs offering medications provide comprehensive obesity care (care that goes beyond a prescription to include nutritional guidance, behavioral support, physical activity, mental health support and referral, when appropriate, to metabolic and bariatric surgery). The FDA warns against unapproved or copycat medications, which may be unsafe or ineffective, and has pledged swift action against companies marketing them. This underscores the importance of discussing treatment options with a qualified clinician and advocating for broader access and coverage. OAC continues to advocate for patient-centered policies, the elimination of weight bias and improved coverage so evidence-based obesity treatment is accessible to all.